The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study
Matina Kouvari(Beth Israel Deaconess Medical Center), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Georgios Markakis(National and Kapodistrian University of Athens), Laura Valenzuela‐Vallejo(Beth Israel Deaconess Medical Center), Valentina Guatibonza-García(Beth Israel Deaconess Medical Center), Ornella Verrastro(Agostino Gemelli University Polyclinic), Geltrude Mingrone(University of the Sacred Heart), Mohammed Eslam(The University of Sydney), Giulia Angelini(Università Cattolica del Sacro Cuore), Michail Kokkorakis(Harvard University), Jacob George(University of Dundee), Angeliki Katsarou(Beth Israel Deaconess Medical Center), Sophia C. Mylonakis(Houston Methodist)
Cited by 18
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k